ClinicalTrials.gov
ClinicalTrials.gov Menu

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01138605
Recruitment Status : Completed
First Posted : June 7, 2010
Last Update Posted : January 9, 2018
Sponsor:
Information provided by (Responsible Party):
Janssen Sciences Ireland UC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 23, 2017
  Actual Study Completion Date : November 23, 2017